Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    ARUBA
Show Display Options
Rank Status Study
1 Completed Aruba Aloe Formula F-BC-096 in the Treatment of Split Thickness Donor Site After Wound Closure
Condition: Wounds
Interventions: Other: Nivea Cream for scar hydration;   Other: Aloë Vera FORMULA F-BC-096 for scar hydration;   Other: Eucerin Calming cream for scar hydration;   Other: Aloë Vera with modified preservative for scar hydration
2 Suspended Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure
Condition: Hydration of Scars
Intervention: Drug: Application of Aruba Aloë formula F-BC-096 or control
3 Completed A Randomized Trial of Unruptured Brain AVMs
Condition: Arteriovenous Malformations, Cerebral
Interventions: Procedure: Interventional therapy;   Other: Medical management
4 Recruiting RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection
Condition: Chikungunya Fever

Indicates status has not been verified in more than two years